Three-Year Outcomes in Discharged Survivors of COVID-19 Following the SARS-CoV-2 Omicron Wave in 2022 in China
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The Lancet Respiratory Medicine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
3-year outcomes of discharged survivors of COVID-19 following the SARS-CoV-2 omicron (B.1.1.529) wave in 2022 in China: a longitudinal cohort study
Lancet Respir Med 2023 Nov 21;[EPub Ahead of Print], H Zhang, C Huang, X Gu, Y Wang, X Li, M Liu, Q Wang, J Xu, Y Wang, H Dai, D Zhang, B CaoFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.